ReP USP - Resultado da busca

Artigo de periodico
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis (2012)
Barichello, Tatiana; Ceretta, Renan A.; Generoso, Jaqueline S.; Moreira, Ana Paula; Simões, Lutiana R.; Comim, Clarissa M.; Quevedo, João; Vilela, Márcia Carvalho; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Teixeira, Antonio Lúcio
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: STREPTOCOCCUS, MENINGITE, CITOCINAS, CANNABIS, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARICHELLO, Tatiana et al. Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis. European Journal of Pharmacology, v. 697, n. 1-3, p. 158-164, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2012.09.053. Acesso em: 01 set. 2024.
APA
Barichello, T., Ceretta, R. A., Generoso, J. S., Moreira, A. P., Simões, L. R., Comim, C. M., et al. (2012). Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis. European Journal of Pharmacology, 697( 1-3), 158-164. doi:10.1016/j.ejphar.2012.09.053
NLM
Barichello T, Ceretta RA, Generoso JS, Moreira AP, Simões LR, Comim CM, Quevedo J, Vilela MC, Zuardi AW, Crippa JA de S, Teixeira AL. Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis [Internet]. European Journal of Pharmacology. 2012 ; 697( 1-3): 158-164.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2012.09.053
Vancouver
Barichello T, Ceretta RA, Generoso JS, Moreira AP, Simões LR, Comim CM, Quevedo J, Vilela MC, Zuardi AW, Crippa JA de S, Teixeira AL. Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis [Internet]. European Journal of Pharmacology. 2012 ; 697( 1-3): 158-164.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2012.09.053
Artigo de periodico
Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test (2008)
Lisboa, Sabrina F.; Resstel, Leonardo Barbosa Moraes; Aguiar, Daniele C.; Guimarães, Francisco Silveira
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: ANSIEDADE, CANNABIS, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, Sabrina F. et al. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test. European Journal of Pharmacology, v. 593, n. 1-3, p. 73-78, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.07.032. Acesso em: 01 set. 2024.
APA
Lisboa, S. F., Resstel, L. B. M., Aguiar, D. C., & Guimarães, F. S. (2008). Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test. European Journal of Pharmacology, 593( 1-3), 73-78. doi:10.1016/j.ejphar.2008.07.032
NLM
Lisboa SF, Resstel LBM, Aguiar DC, Guimarães FS. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test [Internet]. European Journal of Pharmacology. 2008 ; 593( 1-3): 73-78.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2008.07.032
Vancouver
Lisboa SF, Resstel LBM, Aguiar DC, Guimarães FS. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test [Internet]. European Journal of Pharmacology. 2008 ; 593( 1-3): 73-78.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2008.07.032
Artigo de periodico
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice (2005)
Moreira, Fabrício A.; Guimarães, Francisco Silveira
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: TERPENOS, CANNABIS, ANTIPSICÓTICOS, LOCOMOÇÃO, CATALEPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fabrício A. e GUIMARÃES, Francisco Silveira. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. European Journal of Pharmacology, v. 512, p. 199-205, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.02.040. Acesso em: 01 set. 2024.
APA
Moreira, F. A., & Guimarães, F. S. (2005). Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. European Journal of Pharmacology, 512, 199-205. doi:10.1016/j.ejphar.2005.02.040
NLM
Moreira FA, Guimarães FS. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice [Internet]. European Journal of Pharmacology. 2005 ; 512 199-205.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2005.02.040
Vancouver
Moreira FA, Guimarães FS. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice [Internet]. European Journal of Pharmacology. 2005 ; 512 199-205.[citado 2024 set. 01 ] Available from: https://doi.org/10.1016/j.ejphar.2005.02.040

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em